ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA

Clinical trials for ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Weight-Loss drugs tested as potential cancer treatment

Disease control Recruiting now

This study is testing whether popular weight-loss medications (GLP-1RAs) can help treat early-stage endometrial cancer when used alongside a hormonal IUD. It is for obese patients who are not good candidates for surgery or who wish to preserve their fertility. The goal is to see …

Matched conditions: ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA

Get alerted when new ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA trials appear

Weight-Loss drugs tested as potential cancer treatment